Features, pricing, ratings, and pros & cons — compared head-to-head.
Ivanti Neurons for App Control is a commercial endpoint protection platform tool by Ivanti. SentryBay Armored Client AVD W365 is a commercial endpoint protection platform tool by SentryBay. Compare features, ratings, integrations, and community reviews side by side to find the best endpoint protection platform fit for your security stack.
Based on our analysis of NIST CSF 2.0 coverage, core features, integrations, company size fit, here is our conclusion:
Ivanti Neurons for App Control
Mid-market and enterprise teams drowning in unauthorized application execution and privilege creep will get real value from Ivanti Neurons for App Control because its ownership-based rules tied to NTFS security actually stick without constant tuning. The cloud-native audit-then-enforce workflow means you can test configurations against your real endpoint population before locking anything down, which beats the guess-and-patch cycle of traditional allowlisting. Skip this if your priority is behavioral threat detection; Ivanti owns access control and privilege elevation tracking (NIST PR.AA and PR.PS), not anomaly hunting.
SentryBay Armored Client AVD W365
Mid-market and enterprise teams standardizing on Azure Virtual Desktop or Windows 365 should evaluate SentryBay Armored Client AVD W365 for its endpoint isolation model, which neutralizes zero-day attacks by design rather than detection. The tool's focus on identity-driven access control (NIST PR.AA) and unmanaged device authentication addresses a real gap in AVD deployments where traditional EDR struggles with ephemeral, non-persistent endpoints. Skip this if your organization needs behavioral analytics or threat hunting capabilities; SentryBay prioritizes containment and compliance (HIPAA, PCI DSS, GDPR) over investigation, which means you'll still need separate detection tooling.
Application control and privilege management for endpoint security
Endpoint access isolation for Azure Virtual Desktop and Windows 365 devices
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing Ivanti Neurons for App Control vs SentryBay Armored Client AVD W365 for your endpoint protection platform needs.
Ivanti Neurons for App Control: Application control and privilege management for endpoint security. built by Ivanti. Core capabilities include Trusted ownership-based application control using NTFS security, Privilege management for application-specific admin rights elevation, Granular allow and deny rules for application access control..
SentryBay Armored Client AVD W365: Endpoint access isolation for Azure Virtual Desktop and Windows 365 devices. built by SentryBay. Core capabilities include Endpoint access isolation, Zero-day threat neutralization, Unmanaged device authentication..
Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.
Ivanti Neurons for App Control differentiates with Trusted ownership-based application control using NTFS security, Privilege management for application-specific admin rights elevation, Granular allow and deny rules for application access control. SentryBay Armored Client AVD W365 differentiates with Endpoint access isolation, Zero-day threat neutralization, Unmanaged device authentication.
Ivanti Neurons for App Control is developed by Ivanti. SentryBay Armored Client AVD W365 is developed by SentryBay. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.
Ivanti Neurons for App Control and SentryBay Armored Client AVD W365 serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools, both cover Zero Day. Review the feature comparison above to determine which fits your requirements.
Get strategic cybersecurity insights in your inbox